{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:46:42Z","timestamp":1793832402561,"version":"4.6.1"},"reference-count":136,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81471048"],"award-info":[{"award-number":["81471048"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"crossref","award":["ZR2012HL42"],"award-info":[{"award-number":["ZR2012HL42"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Project of Shandong Province Higher Educational Science and Technology Program","award":["J12LK01"],"award-info":[{"award-number":["J12LK01"]}]},{"name":"Doctoral Scientific Research Foundation of Weifang Medical University","award":["2017BSQD01"],"award-info":[{"award-number":["2017BSQD01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12985-018-0937-3","type":"journal-article","created":{"date-parts":[[2018,2,6]],"date-time":"2018-02-06T13:15:13Z","timestamp":1517922913000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Human cytomegalovirus infection and coronary heart disease: a systematic review"],"prefix":"10.1186","volume":"15","author":[{"given":"Yu","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangxue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2323-462X","authenticated-orcid":false,"given":"Zhijun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,6]]},"reference":[{"key":"937_CR1","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1017\/S1047951116001396","volume":"27","author":"M Tyagi","year":"2017","unstructured":"Tyagi M, Fteropoulli T, Hurt CS, Hirani SP, Rixon L, Davies A, Picaut N, Kennedy F, Deanfield J, Cullen S, Newman SP. Cognitive dysfunction in adult CHD with different structural complexity. Cardiol Young. 2017;27:851\u20139.","journal-title":"Cardiol Young"},{"key":"937_CR2","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1016\/j.jacc.2016.08.069","volume":"68","author":"A Arbab-Zadeh","year":"2016","unstructured":"Arbab-Zadeh A, Fuster V. The risk continuum of atherosclerosis and its implications for defining CHD by coronary angiography. J Am Coll Cardiol. 2016;68:2467\u201378.","journal-title":"J Am Coll Cardiol"},{"key":"937_CR3","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/nrcardio.2014.26","volume":"11","author":"ND Wong","year":"2014","unstructured":"Wong ND. Epidemiological studies of CHD and the evolution of preventive cardiology. Nat Rev Cardiol. 2014;11:276\u201389.","journal-title":"Nat Rev Cardiol"},{"key":"937_CR4","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.urology.2010.04.065","volume":"77","author":"S Takada","year":"2011","unstructured":"Takada S, Kurita Y, Imanishi T, Otsuka A, Shinbo H, Furuse H, Nakanishi T, Suzuki A, Takase H, Ozono S. Arteriosclerosis related factors had no clinical significant correlation with resistive index in symptomatic benign prostatic hyperplasia. Urology. 2011;77:433\u20137.","journal-title":"Urology"},{"key":"937_CR5","doi-asserted-by":"publisher","first-page":"440","DOI":"10.5935\/1678-9741.20110020","volume":"26","author":"EL Ramalli Jr","year":"2011","unstructured":"Ramalli EL Jr, Braga LH, Evora PM, Albuquerque AA, Celotto AC, Mota AL, Evora PR. Absence of arteriosclerosis in intramyocardial coronary arteries: a mystery to be solved? Rev Bras Cir Cardiovasc. 2011;26:440\u20136.","journal-title":"Rev Bras Cir Cardiovasc"},{"key":"937_CR6","doi-asserted-by":"crossref","first-page":"8215082","DOI":"10.1155\/2016\/8215082","volume":"2016","author":"L Ma","year":"2016","unstructured":"Ma L, Zhang J, Liu Y. Roles and mechanisms of obstructive sleep Apnea-Hypopnea syndrome and chronic intermittent hypoxia in atherosclerosis: evidence and prospective. Oxidative Med Cell Longev. 2016;2016:8215082.","journal-title":"Oxidative Med Cell Longev"},{"key":"937_CR7","doi-asserted-by":"publisher","first-page":"523","DOI":"10.2169\/internalmedicine.52.8858","volume":"52","author":"T Ohnuki","year":"2013","unstructured":"Ohnuki T, Takahashi W, Ohnuki Y, Kawada S, Takizawa S. Significance of the presence of metabolic syndrome in patients with asymptomatic arteriosclerosis affecting the aorta and the cerebral, extra-cranial carotid and coronary arteries. Intern Med. 2013;52:523\u20137.","journal-title":"Intern Med"},{"key":"937_CR8","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1253\/circj.CJ-07-1049","volume":"72","author":"Japan Arteriosclerosis Longitudinal Study G","year":"2008","unstructured":"Japan Arteriosclerosis Longitudinal Study G. Japan arteriosclerosis longitudinal study-existing cohorts combine (JALS-ECC): rationale, design, and population characteristics. Circ J. 2008;72:1563\u20138.","journal-title":"Circ J"},{"key":"937_CR9","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.carpath.2015.07.007","volume":"24","author":"MC Fishbein","year":"2015","unstructured":"Fishbein MC, Fishbein GA. Arteriosclerosis: facts and fancy. Cardiovasc Pathol. 2015;24:335\u201342.","journal-title":"Cardiovasc Pathol"},{"key":"937_CR10","first-page":"916","volume":"45","author":"Y Liu","year":"2013","unstructured":"Liu Y, Qi LT, Ma W, Yang Y, Meng L, Zhang BW, Huo Y. Relationship between radial augmentation index and other indices for evaluating arteriosclerosis. Beijing Da Xue Xue Bao. 2013;45:916\u201322.","journal-title":"Beijing Da Xue Xue Bao"},{"key":"937_CR11","doi-asserted-by":"publisher","first-page":"30","DOI":"10.5761\/atcs.oa.12.02061","volume":"19","author":"S Ren","year":"2013","unstructured":"Ren S, Qian S, Wang W, Liu J, Liu P. Prospective study of sarpogrelate hydrochloride on patients with arteriosclerosis obliterans. Ann Thorac Cardiovasc Surg. 2013;19:30\u20134.","journal-title":"Ann Thorac Cardiovasc Surg"},{"issue":"Suppl 3","key":"937_CR12","first-page":"III\/56","volume":"94","author":"G Bonner","year":"2005","unstructured":"Bonner G, Gysan DB, Sauer G. Prevention of arteriosclerosis. Importance of the treatment of arterial hypertension. Z Kardiol. 2005;94(Suppl 3):III\/56\u201365.","journal-title":"Z Kardiol"},{"key":"937_CR13","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.pmedr.2016.06.006","volume":"4","author":"R Shimizu","year":"2016","unstructured":"Shimizu R, Torii H, Yasuda D, Hiraoka Y, Furukawa Y, Yoshimoto A, Iwakura T, Matsuoka N, Tomii K, Kohara N, et al. Comparison of serum lipid management between elderly and non-elderly patients with and without coronary heart disease (CHD). Prev Med Rep. 2016;4:192\u20138.","journal-title":"Prev Med Rep"},{"key":"937_CR14","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1097\/HJR.0b013e328336a138","volume":"17","author":"TL Ahola","year":"2010","unstructured":"Ahola TL, Kantola IM, Puukka P, Kattainen A, Klaukka T, Reunanen A, Jula AM. Positive change in the utilization of antihypertensive and lipid-lowering drugs among adult CHD patients in Finland: results from a large national database between 2000 and 2006. Eur J Cardiovasc Prev Rehabil. 2010;17:477\u201385.","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"937_CR15","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1097\/00149831-200410000-00003","volume":"11","author":"CE Koro","year":"2004","unstructured":"Koro CE, L'Italien GJ, Fedder DO. Major CHD risk factors predominate among African-American women who are eligible for lipid-lowering drug therapy under the new ATP III guidelines. Eur J Cardiovasc Prev Rehabil. 2004;11:376\u201381.","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"937_CR16","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/sj.jhh.1001882","volume":"19","author":"JC Eisenmann","year":"2005","unstructured":"Eisenmann JC, Wrede J, Heelan KA. Associations between adiposity, family history of CHD and blood pressure in 3-8 year-old children. J Hum Hypertens. 2005;19:675\u201381.","journal-title":"J Hum Hypertens"},{"key":"937_CR17","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.ypmed.2004.06.013","volume":"40","author":"LJ Brandon","year":"2005","unstructured":"Brandon LJ, Mullis RM, Jonnalagadda SS, Hughes MH. Relationships and CHD risks of BMI, lipoproteins, lipids, and blood pressure in African-American men and women. Prev Med. 2005;40:349\u201354.","journal-title":"Prev Med"},{"key":"937_CR18","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1186\/1471-2458-9-294","volume":"9","author":"Asia Pacific Cohort Studies C","year":"2009","unstructured":"Asia Pacific Cohort Studies C. Impact of cigarette smoking on the relationship between body mass index and coronary heart disease: a pooled analysis of 3264 stroke and 2706 CHD events in 378579 individuals in the Asia Pacific region. BMC Public Health. 2009;9:294.","journal-title":"BMC Public Health"},{"key":"937_CR19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.amepre.2008.09.030","volume":"36","author":"JM Lightwood","year":"2009","unstructured":"Lightwood JM, Coxson PG, Bibbins-Domingo K, Williams LW, Goldman L. Coronary heart disease attributable to passive smoking: CHD policy model. Am J Prev Med. 2009;36:13\u201320.","journal-title":"Am J Prev Med"},{"key":"937_CR20","first-page":"675","volume":"57","author":"SM Frothingham","year":"2008","unstructured":"Frothingham SM, Smith PO, Payne TJ, Meadows SE. Clinical inquiries: how much does smoking cessation cut CHD risk? J Fam Pract. 2008;57:675\u20136.","journal-title":"J Fam Pract"},{"key":"937_CR21","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/S1361-2611(97)80004-8","volume":"1","author":"G Fowler","year":"1997","unstructured":"Fowler G. Passive smoking was associated with an increased risk of CHD. Evid Based Cardiovasc Med. 1997;1:92.","journal-title":"Evid Based Cardiovasc Med"},{"key":"937_CR22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1375\/twin.8.1.53","volume":"8","author":"A Wienke","year":"2005","unstructured":"Wienke A, Herskind AM, Christensen K, Skytthe A, Yashin AI. The heritability of CHD mortality in danish twins after controlling for smoking and BMI. Twin Res Hum Genet. 2005;8:53\u20139.","journal-title":"Twin Res Hum Genet"},{"key":"937_CR23","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.ypmed.2003.12.022","volume":"38","author":"C Diverse Populations","year":"2004","unstructured":"Diverse Populations C. Smoking, body weight, and CHD mortality in diverse populations. Prev Med. 2004;38:834\u201340.","journal-title":"Prev Med"},{"key":"937_CR24","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/ajim.22525","volume":"59","author":"MY Kang","year":"2016","unstructured":"Kang MY, Hong YC. Inter-correlation between working hours, sleep duration, obesity, and 10-year risk for CHD. Am J Ind Med. 2016;59:338\u20139.","journal-title":"Am J Ind Med"},{"key":"937_CR25","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1080\/AC.70.4.3096897","volume":"70","author":"GM Lin","year":"2015","unstructured":"Lin GM, Li YH, Lai CP, Lin CL, Wang JH. The obesity-mortality paradox in elderly patients with angiographic coronary artery disease: a report from the ET-CHD registry. Acta Cardiol. 2015;70:479\u201386.","journal-title":"Acta Cardiol"},{"key":"937_CR26","first-page":"208","volume":"25","author":"J Kwagyan","year":"2015","unstructured":"Kwagyan J, Retta TM, Ketete M, Bettencourt CN, Maqbool AR, Xu S, Randall OS. Obesity and cardiovascular diseases in a high-risk population: evidence-based approach to CHD risk reduction. Ethn Dis. 2015;25:208\u201313.","journal-title":"Ethn Dis"},{"key":"937_CR27","first-page":"5","volume":"255","author":"J Logue","year":"2011","unstructured":"Logue J. Obesity is an independent risk factor for death from CHD. Practitioner. 2011;255:5.","journal-title":"Practitioner"},{"key":"937_CR28","first-page":"166","volume":"12","author":"A Ghosh","year":"2003","unstructured":"Ghosh A, Bose K, Das Chaudhuri AB. Association of food patterns, central obesity measures and metabolic risk factors for coronary heart disease (CHD) in middle aged Bengalee Hindu men, Calcutta, India. Asia Pac J Clin Nutr. 2003;12:166\u201371.","journal-title":"Asia Pac J Clin Nutr"},{"key":"937_CR29","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1053\/euhj.1999.2023","volume":"21","author":"C Brotons","year":"2000","unstructured":"Brotons C, Soler-Soler J. Obesity, Cinderella of CHD risk factors. Eur Heart J. 2000;21:793\u20135.","journal-title":"Eur Heart J"},{"key":"937_CR30","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jdiacomp.2015.11.018","volume":"30","author":"N Gao","year":"2016","unstructured":"Gao N, Yuan Z, Tang X, Zhou X, Zhao M, Liu L, Ji J, Xue F, Ning G, Zhao J, et al. Prevalence of CHD-related metabolic comorbidity of diabetes mellitus in northern Chinese adults: the REACTION study. J Diabetes Complicat. 2016;30:199\u2013205.","journal-title":"J Diabetes Complicat"},{"key":"937_CR31","first-page":"7","volume":"258","author":"M Lockyer","year":"2014","unstructured":"Lockyer M. Women with diabetes at greater risk of CHD than men. Practitioner. 2014;258:7.","journal-title":"Practitioner"},{"key":"937_CR32","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1017\/S0007114512001845","volume":"109","author":"SS Soedamah-Muthu","year":"2013","unstructured":"Soedamah-Muthu SS, Masset G, Verberne L, Geleijnse JM, Brunner EJ. Consumption of dairy products and associations with incident diabetes, CHD and mortality in the Whitehall II study. Br J Nutr. 2013;109:718\u201326.","journal-title":"Br J Nutr"},{"key":"937_CR33","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.atherosclerosis.2012.01.026","volume":"222","author":"JH Southerland","year":"2012","unstructured":"Southerland JH, Moss K, Taylor GW, Beck JD, Pankow J, Gangula PR, Offenbacher S. Periodontitis and diabetes associations with measures of atherosclerosis and CHD. Atherosclerosis. 2012;222:196\u2013201.","journal-title":"Atherosclerosis"},{"key":"937_CR34","doi-asserted-by":"publisher","unstructured":"Kucharska-Newton A, Griswold M, Yao ZH, Foraker R, Rose K, Rosamond W, Wagenknecht L, Koton S, Pompeii L, Windham BG. Cardiovascular disease and patterns of change in functional status over 15 years: findings from the atherosclerosis risk in communities (ARIC) study. J Am Heart Assoc. 2017;6:e004144. https:\/\/doi.org\/10.1161\/JAHA.116.004144 .","DOI":"10.1161\/JAHA.116.004144"},{"key":"937_CR35","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1160\/TH16-02-0091","volume":"116","author":"C Weber","year":"2016","unstructured":"Weber C, Shantsila E, Hristov M, Caligiuri G, Guzik T, Heine GH, Hoefer IE, Monaco C, Peter K, Rainger E, et al. Role and analysis of monocyte subsets in cardiovascular disease. Joint consensus document of the European Society of Cardiology (ESC) working groups \u201cAtherosclerosis & Vascular Biology\u201d and \u201cthrombosis\u201d. Thromb Haemost. 2016;116:626\u201337.","journal-title":"Thromb Haemost"},{"key":"937_CR36","doi-asserted-by":"publisher","unstructured":"Yazouli LE, Criscuolo A, Hejaji H, Bouaaza M, Elmdaghri N, Alami AA, Amraoui A, Dakka N, Radouani F. Molecular characterization of Chlamydia pneumoniae associated to atherosclerosis. Pathog Dis. 2017;75. https:\/\/doi.org\/10.1093\/femspd\/ftx039 .","DOI":"10.1093\/femspd\/ftx039"},{"key":"937_CR37","first-page":"188","volume":"66","author":"K Patil","year":"2016","unstructured":"Patil K, Campbell LA, Rosenfeld ME, Paik J, Brabb T, O'Brien KD, Maggio-Price L, Hsu CC. Effects of Murine Norovirus on Chlamydia pneumoniae-accelerated atherosclerosis in ApoE(\u2212\/\u2212) mice. Comp Med. 2016;66:188\u201396.","journal-title":"Comp Med"},{"key":"937_CR38","doi-asserted-by":"publisher","first-page":"378658","DOI":"10.1155\/2015\/378658","volume":"2015","author":"S Filardo","year":"2015","unstructured":"Filardo S, Di Pietro M, Farcomeni A, Schiavoni G, Sessa R. Chlamydia pneumoniae-mediated inflammation in atherosclerosis: a meta-analysis. Mediat Inflamm. 2015;2015:378658.","journal-title":"Mediat Inflamm"},{"key":"937_CR39","doi-asserted-by":"publisher","unstructured":"Zafiratos MT, Manam S, Henderson KK, Ramsey KH, Murthy AK. CD8+ T cells mediate Chlamydia pneumoniae-induced atherosclerosis in mice. Pathog Dis. 2015;73. https:\/\/doi.org\/10.1093\/femspd\/ftv052 .","DOI":"10.1093\/femspd\/ftv052"},{"key":"937_CR40","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.cellimm.2015.01.007","volume":"294","author":"R Sorrentino","year":"2015","unstructured":"Sorrentino R, Yilmaz A, Schubert K, Crother TR, Pinto A, Shimada K, Arditi M, Chen S. A single infection with Chlamydia pneumoniae is sufficient to exacerbate atherosclerosis in ApoE deficient mice. Cell Immunol. 2015;294:25\u201332.","journal-title":"Cell Immunol"},{"key":"937_CR41","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s12192-012-0378-7","volume":"18","author":"S Kreutmayer","year":"2013","unstructured":"Kreutmayer S, Csordas A, Kern J, Maass V, Almanzar G, Offterdinger M, Ollinger R, Maass M, Wick G. Chlamydia pneumoniae infection acts as an endothelial stressor with the potential to initiate the earliest heat shock protein 60-dependent inflammatory stage of atherosclerosis. Cell Stress Chaperones. 2013;18:259\u201368.","journal-title":"Cell Stress Chaperones"},{"key":"937_CR42","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.atherosclerosis.2012.02.005","volume":"222","author":"X Zhao","year":"2012","unstructured":"Zhao X, Bu DX, Hayfron K, Pinkerton KE, Bevins CL, Lichtman A, Wiedeman J. A combination of secondhand cigarette smoke and Chlamydia pneumoniae accelerates atherosclerosis. Atherosclerosis. 2012;222:59\u201366.","journal-title":"Atherosclerosis"},{"key":"937_CR43","first-page":"4067685","volume":"2016","author":"Z Wang","year":"2016","unstructured":"Wang Z, Cai J, Zhang M, Wang X, Chi H, Feng H, Yang X. Positive expression of human cytomegalovirus Phosphoprotein 65 in atherosclerosis. Biomed Res Int. 2016;2016:4067685.","journal-title":"Biomed Res Int"},{"key":"937_CR44","doi-asserted-by":"publisher","first-page":"4102","DOI":"10.12659\/MSM.896071","volume":"21","author":"J Zhang","year":"2015","unstructured":"Zhang J, Liu YY, Sun HL, Li S, Xiong HR, Yang ZQ, Xiang GD, Jiang XJ. High human cytomegalovirus IgG level is associated with increased incidence of diabetic atherosclerosis in type 2 diabetes mellitus patients. Med Sci Monit. 2015;21:4102\u201310.","journal-title":"Med Sci Monit"},{"key":"937_CR45","doi-asserted-by":"publisher","first-page":"e15476","DOI":"10.5812\/jjm.15476","volume":"8","author":"H Heybar","year":"2015","unstructured":"Heybar H, Alavi SM, Farashahi Nejad M, Latifi M. Cytomegalovirus infection and atherosclerosis in candidate of coronary artery bypass graft. Jundishapur J Microbiol. 2015;8:e15476.","journal-title":"Jundishapur J Microbiol"},{"key":"937_CR46","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.cca.2015.03.015","volume":"445","author":"SJ Jeong","year":"2015","unstructured":"Jeong SJ, Ku NS, Han SH, Choi JY, Kim CO, Song YG, Kim JM. Anti-cytomegalovirus antibody levels are associated with carotid atherosclerosis and inflammatory cytokine production in elderly Koreans. Clin Chim Acta. 2015;445:65\u20139.","journal-title":"Clin Chim Acta"},{"key":"937_CR47","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jns.2016.01.025","volume":"362","author":"Y Xu","year":"2016","unstructured":"Xu Y, Wang Q, Liu Y, Cui R, Lu K, Zhao Y. Association between helicobacter pylori infection and carotid atherosclerosis in patients with vascular dementia. J Neurol Sci. 2016;362:73\u20137.","journal-title":"J Neurol Sci"},{"key":"937_CR48","first-page":"396","volume":"17","author":"A Blum","year":"2015","unstructured":"Blum A. Helicobacter pylori and atherosclerosis. Isr Med Assoc J. 2015;17:396.","journal-title":"Isr Med Assoc J"},{"key":"937_CR49","first-page":"78","volume":"53","author":"R Karbasi-Afshar","year":"2015","unstructured":"Karbasi-Afshar R, Khedmat H, Izadi M. Helicobacter pylori infection and atherosclerosis: a systematic review. Acta Med Iran. 2015;53:78\u201388.","journal-title":"Acta Med Iran"},{"key":"937_CR50","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.5551\/jat.25775","volume":"21","author":"C He","year":"2014","unstructured":"He C, Yang Z, Lu NH. Helicobacter pylori-an infectious risk factor for atherosclerosis? J Atheroscler Thromb. 2014;21:1229\u201342.","journal-title":"J Atheroscler Thromb"},{"key":"937_CR51","doi-asserted-by":"publisher","first-page":"570597","DOI":"10.1155\/2013\/570597","volume":"2013","author":"SG Kang","year":"2013","unstructured":"Kang SG, Chung WC, Song SW, Joo KR, Lee H, Kang D, Lee JS, Lee KM. Risk of atherosclerosis and helicobacter pylori infection according to CD14 Promotor polymorphism in healthy Korean population. Gastroenterol Res Pract. 2013;2013:570597.","journal-title":"Gastroenterol Res Pract"},{"key":"937_CR52","first-page":"2476","volume":"42","author":"CG Fabricant","year":"1983","unstructured":"Fabricant CG, Fabricant J, Minick CR, Litrenta MM. Herpesvirus-induced atherosclerosis in chickens. Fed Proc. 1983;42:2476\u20139.","journal-title":"Fed Proc"},{"key":"937_CR53","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1097\/QAD.0b013e328351f780","volume":"26","author":"K Sacre","year":"2012","unstructured":"Sacre K, Hunt PW, Hsue PY, Maidji E, Martin JN, Deeks SG, Autran B, McCune JM. A role for cytomegalovirus-specific CD4+CX3CR1+ T cells and cytomegalovirus-induced T-cell immunopathology in HIV-associated atherosclerosis. AIDS. 2012;26:805\u201314.","journal-title":"AIDS"},{"key":"937_CR54","doi-asserted-by":"publisher","first-page":"e473","DOI":"10.1371\/journal.pone.0000473","volume":"2","author":"C Lunardi","year":"2007","unstructured":"Lunardi C, Dolcino M, Peterlana D, Bason C, Navone R, Tamassia N, Tinazzi E, Beri R, Corrocher R, Puccetti A. Endothelial cells\u2019 activation and apoptosis induced by a subset of antibodies against human cytomegalovirus: relevance to the pathogenesis of atherosclerosis. PLoS One. 2007;2:e473.","journal-title":"PLoS One"},{"key":"937_CR55","first-page":"42","volume":"12","author":"C Grahame-Clarke","year":"2005","unstructured":"Grahame-Clarke C. Human cytomegalovirus, endothelial function and atherosclerosis. Herpesviridae. 2005;12:42\u20135.","journal-title":"Herpesviridae"},{"key":"937_CR56","doi-asserted-by":"publisher","first-page":"e113","DOI":"10.1161\/01.ATV.0000170130.85334.38","volume":"25","author":"PS Olofsson","year":"2005","unstructured":"Olofsson PS, Jatta K, Wagsater D, Gredmark S, Hedin U, Paulsson-Berne G, Soderberg-Naucler C, Hansson GK, Sirsjo A. The antiviral cytomegalovirus inducible gene 5\/viperin is expressed in atherosclerosis and regulated by proinflammatory agents. Arterioscler Thromb Vasc Biol. 2005;25:e113\u20136.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"937_CR57","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1016\/S0140-6736(03)15016-7","volume":"362","author":"C Bason","year":"2003","unstructured":"Bason C, Corrocher R, Lunardi C, Puccetti P, Olivieri O, Girelli D, Navone R, Beri R, Millo E, Margonato A, et al. Interaction of antibodies against cytomegalovirus with heat-shock protein 60 in pathogenesis of atherosclerosis. Lancet. 2003;362:1971\u20137.","journal-title":"Lancet"},{"key":"937_CR58","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1023\/A:1024759311013","volume":"249","author":"R Chen","year":"2003","unstructured":"Chen R, Xiong S, Yang Y, Fu W, Wang Y, Ge J. The relationship between human cytomegalovirus infection and atherosclerosis development. Mol Cell Biochem. 2003;249:91\u20136.","journal-title":"Mol Cell Biochem"},{"key":"937_CR59","first-page":"297","volume":"44","author":"JL Melnick","year":"1996","unstructured":"Melnick JL, Adam E, DeBakey ME. Cytomegalovirus and atherosclerosis. Arch Immunol Ther Exp. 1996;44:297\u2013302.","journal-title":"Arch Immunol Ther Exp"},{"key":"937_CR60","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/S0140-6736(83)92529-1","volume":"2","author":"JL Melnick","year":"1983","unstructured":"Melnick JL, Petrie BL, Dreesman GR, Burek J, McCollum CH, DeBakey ME. Cytomegalovirus antigen within human arterial smooth muscle cells. Lancet. 1983;2:644\u20137.","journal-title":"Lancet"},{"key":"937_CR61","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S1386-6532(99)00064-5","volume":"16","author":"R Horvath","year":"2000","unstructured":"Horvath R, Cerny J, Benedik J Jr, Hokl J, Jelinkova I, Benedik J. The possible role of human cytomegalovirus (HCMV) in the origin of atherosclerosis. J Clin Virol. 2000;16:17\u201324.","journal-title":"J Clin Virol"},{"key":"937_CR62","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S0140-6736(87)90888-9","volume":"2","author":"E Adam","year":"1987","unstructured":"Adam E, Melnick JL, Probtsfield JL, Petrie BL, Burek J, Bailey KR, McCollum CH, DeBakey ME. High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis. Lancet. 1987;2:291\u20133.","journal-title":"Lancet"},{"key":"937_CR63","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1536\/ihj.46.205","volume":"46","author":"NK Eryol","year":"2005","unstructured":"Eryol NK, Kilic H, Gul A, Ozdogru I, Inanc T, Dogan A, Topsakal R, Basar E. Are the high levels of cytomegalovirus antibodies a determinant in the development of coronary artery disease? Int Heart J. 2005;46:205\u20139.","journal-title":"Int Heart J"},{"key":"937_CR64","doi-asserted-by":"publisher","first-page":"e16103","DOI":"10.1371\/journal.pone.0016103","volume":"6","author":"AM Simanek","year":"2011","unstructured":"Simanek AM, Dowd JB, Pawelec G, Melzer D, Dutta A, Aiello AE. Seropositivity to cytomegalovirus, inflammation, all-cause and cardiovascular disease-related mortality in the United States. PLoS One. 2011;6:e16103.","journal-title":"PLoS One"},{"key":"937_CR65","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1093\/infdis\/jis620","volume":"206","author":"E Gkrania-Klotsas","year":"2012","unstructured":"Gkrania-Klotsas E, Langenberg C, Sharp SJ, Luben R, Khaw KT, Wareham NJ. Higher immunoglobulin G antibody levels against cytomegalovirus are associated with incident ischemic heart disease in the population-based EPIC-Norfolk cohort. J Infect Dis. 2012;206:1897\u2013903.","journal-title":"J Infect Dis"},{"key":"937_CR66","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1001\/archinte.160.13.2027","volume":"160","author":"PD Sorlie","year":"2000","unstructured":"Sorlie PD, Nieto FJ, Adam E, Folsom AR, Shahar E, Massing M. A prospective study of cytomegalovirus, herpes simplex virus 1, and coronary heart disease: the atherosclerosis risk in communities (ARIC) study. Arch Intern Med. 2000;160:2027\u201332.","journal-title":"Arch Intern Med"},{"key":"937_CR67","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/jmv.1890420107","volume":"42","author":"PD Sorlie","year":"1994","unstructured":"Sorlie PD, Adam E, Melnick SL, Folsom A, Skelton T, Chambless LE, Barnes R, Melnick JL. Cytomegalovirus\/herpesvirus and carotid atherosclerosis: the ARIC study. J Med Virol. 1994;42:33\u20137.","journal-title":"J Med Virol"},{"key":"937_CR68","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1177\/0003319708322390","volume":"60","author":"E Xenaki","year":"2009","unstructured":"Xenaki E, Hassoulas J, Apostolakis S, Sourvinos G, Spandidos DA. Detection of cytomegalovirus in atherosclerotic plaques and nonatherosclerotic arteries. Angiology. 2009;60:504\u20138.","journal-title":"Angiology"},{"key":"937_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0166-0934(03)00035-1","volume":"109","author":"B Reinhardt","year":"2003","unstructured":"Reinhardt B, Vaida B, Voisard R, Keller L, Breul J, Metzger H, Herter T, Baur R, Luske A, Mertens T. Human cytomegalovirus infection in human renal arteries in vitro. J Virol Methods. 2003;109:1\u20139.","journal-title":"J Virol Methods"},{"key":"937_CR70","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/j.1600-6143.2007.02062.x","volume":"8","author":"DN Streblow","year":"2008","unstructured":"Streblow DN, Kreklywich CN, Andoh T, Moses AV, Dumortier J, Smith PP, Defilippis V, Fruh K, Nelson JA, Orloff SL. The role of angiogenic and wound repair factors during CMV-accelerated transplant vascular sclerosis in rat cardiac transplants. Am J Transplant. 2008;8:277\u201387.","journal-title":"Am J Transplant"},{"key":"937_CR71","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1016\/S0041-1345(00)02729-9","volume":"33","author":"VT De La Melena","year":"2001","unstructured":"De La Melena VT, Kreklywich CN, Streblow DN, Yin Q, Cook JW, Soderberg-Naucler C, Bruggeman CA, Nelson JA, Orloff SL. Kinetics and development of CMV-accelerated transplant vascular sclerosis in rat cardiac allografts is linked to early increase in chemokine expression and presence of virus. Transplant Proc. 2001;33:1822\u20133.","journal-title":"Transplant Proc"},{"key":"937_CR72","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/modpathol.3880032","volume":"13","author":"NV Sambiase","year":"2000","unstructured":"Sambiase NV, Higuchi ML, Nuovo G, Gutierrez PS, Fiorelli AI, Uip DE, Ramires JA. CMV and transplant-related coronary atherosclerosis: an immunohistochemical, in situ hybridization, and polymerase chain reaction in situ study. Mod Pathol. 2000;13:173\u20139.","journal-title":"Mod Pathol"},{"key":"937_CR73","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1093\/qjmed\/91.3.185","volume":"91","author":"S Pouria","year":"1998","unstructured":"Pouria S, State OI, Wong W, Hendry BM. CMV infection is associated with transplant renal artery stenosis. QJM. 1998;91:185\u20139.","journal-title":"QJM"},{"key":"937_CR74","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1084\/jem.148.1.335","volume":"148","author":"CG Fabricant","year":"1978","unstructured":"Fabricant CG, Fabricant J, Litrenta MM, Minick CR. Virus-induced atherosclerosis. J Exp Med. 1978;148:335\u201340.","journal-title":"J Exp Med"},{"key":"937_CR75","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1172\/JCI116622","volume":"92","author":"KB Lemstrom","year":"1993","unstructured":"Lemstrom KB, Bruning JH, Bruggeman CA, Lautenschlager IT, Hayry PJ. Cytomegalovirus infection enhances smooth muscle cell proliferation and intimal thickening of rat aortic allografts. J Clin Invest. 1993;92:549\u201358.","journal-title":"J Clin Invest"},{"key":"937_CR76","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1161\/01.CIR.90.4.1969","volume":"90","author":"KB Lemstrom","year":"1994","unstructured":"Lemstrom KB, Bruning JH, Bruggeman CA, Koskinen PK, Aho PT, Yilmaz S, Lautenschlager IT, Hayry PJ. Cytomegalovirus infection-enhanced allograft arteriosclerosis is prevented by DHPG prophylaxis in the rat. Circulation. 1994;90:1969\u201378.","journal-title":"Circulation"},{"issue":"Suppl 1","key":"937_CR77","doi-asserted-by":"publisher","first-page":"S383","DOI":"10.1111\/j.1432-2277.1994.tb01398.x","volume":"7","author":"KB Lemstrom","year":"1994","unstructured":"Lemstrom KB, Koskinen PK, Bruning JH, Bruggeman CA, Lautenschlager IT, Hayry PJ. Effect of ganciclovir prophylaxis on cytomegalovirus-enhanced allograft arteriosclerosis. Transpl Int. 1994;7(Suppl 1):S383\u20134.","journal-title":"Transpl Int"},{"key":"937_CR78","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.micinf.2004.10.008","volume":"7","author":"G Kloppenburg","year":"2005","unstructured":"Kloppenburg G, de Graaf R, Herngreen S, Grauls G, Bruggeman C, Stassen F. Cytomegalovirus aggravates intimal hyperplasia in rats by stimulating smooth muscle cell proliferation. Microbes Infect. 2005;7:164\u201370.","journal-title":"Microbes Infect"},{"key":"937_CR79","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1161\/01.CIR.102.7.779","volume":"102","author":"DG Alber","year":"2000","unstructured":"Alber DG, Powell KL, Vallance P, Goodwin DA, Grahame-Clarke C. Herpesvirus infection accelerates atherosclerosis in the apolipoprotein E-deficient mouse. Circulation. 2000;102:779\u201385.","journal-title":"Circulation"},{"key":"937_CR80","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1086\/517355","volume":"177","author":"SP Adler","year":"1998","unstructured":"Adler SP, Hur JK, Wang JB, Vetrovec GW. Prior infection with cytomegalovirus is not a major risk factor for angiographically demonstrated coronary artery atherosclerosis. J Infect Dis. 1998;177:209\u201312.","journal-title":"J Infect Dis"},{"key":"937_CR81","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1161\/01.CIR.98.25.2796","volume":"98","author":"PM Ridker","year":"1998","unstructured":"Ridker PM, Hennekens CH, Stampfer MJ, Wang F. Prospective study of herpes simplex virus, cytomegalovirus, and the risk of future myocardial infarction and stroke. Circulation. 1998;98:2796\u20139.","journal-title":"Circulation"},{"key":"937_CR82","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1086\/314634","volume":"179","author":"D Rothenbacher","year":"1999","unstructured":"Rothenbacher D, Hoffmeister A, Bode G, Wanner P, Koenig W, Brenner H. Cytomegalovirus infection and coronary heart disease: results of a german case-control study. J Infect Dis. 1999;179:690\u20132.","journal-title":"J Infect Dis"},{"key":"937_CR83","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1128\/JVI.79.4.2211-2220.2005","volume":"79","author":"A Rahbar","year":"2005","unstructured":"Rahbar A, Soderberg-Naucler C. Human cytomegalovirus infection of endothelial cells triggers platelet adhesion and aggregation. J Virol. 2005;79:2211\u201320.","journal-title":"J Virol"},{"key":"937_CR84","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/xen.12097","volume":"21","author":"A Taveira","year":"2014","unstructured":"Taveira A, Ponroy N, Mueller NJ, Millard AL. Entry of human cytomegalovirus into porcine endothelial cells depends on both the cellular vascular origin and the viral strain. Xenotransplantation. 2014;21:324\u201340.","journal-title":"Xenotransplantation"},{"key":"937_CR85","first-page":"177","volume":"31","author":"FA Niyi-Odumosu","year":"2017","unstructured":"Niyi-Odumosu FA, Bello OA, Biliaminu SA, Owoyele BV, Abu TO, Dominic OL. Resting serum concentration of high-sensitivity C-reactive protein (hs-CRP) in sportsmen and untrained male adults. Niger J Physiol Sci. 2017;31:177\u201381.","journal-title":"Niger J Physiol Sci"},{"key":"937_CR86","first-page":"692","volume":"52","author":"S Mukherjee","year":"2014","unstructured":"Mukherjee S, Barman S, Mandal NC, Bhattacharya S. Anti-bacterial activity of Achatina CRP and its mechanism of action. Indian J Exp Biol. 2014;52:692\u2013704.","journal-title":"Indian J Exp Biol"},{"key":"937_CR87","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s00128-012-0801-x","volume":"89","author":"E Varol","year":"2012","unstructured":"Varol E, Aksoy F, Icli A, Arslan A, Yuksel O, Ersoy IH, Varol S, Dogan A. Increased plasma neopterin and hs-CRP levels in patients with endemic fluorosis. Bull Environ Contam Toxicol. 2012;89:931\u20136.","journal-title":"Bull Environ Contam Toxicol"},{"key":"937_CR88","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S0021-9150(01)00602-5","volume":"160","author":"J De Backer","year":"2002","unstructured":"De Backer J, Mak R, De Bacquer D, Van Renterghem L, Verbraekel E, Kornitzer M, De Backer G. Parameters of inflammation and infection in a community based case-control study of coronary heart disease. Atherosclerosis. 2002;160:457\u201363.","journal-title":"Atherosclerosis"},{"key":"937_CR89","first-page":"78","volume":"49","author":"SM Alavi","year":"2011","unstructured":"Alavi SM, Adel SM, Rajabzadeh AR. An evidence against the effect of chronic cytomegalovirus infection in unstable angina pectoris. Acta Med Iran. 2011;49:78\u201380.","journal-title":"Acta Med Iran"},{"key":"937_CR90","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1016\/j.jacc.2007.02.052","volume":"49","author":"PM Ridker","year":"2007","unstructured":"Ridker PM. C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus. J Am Coll Cardiol. 2007;49:2129\u201338.","journal-title":"J Am Coll Cardiol"},{"key":"937_CR91","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1161\/01.CIR.99.7.855","volume":"99","author":"LM Biasucci","year":"1999","unstructured":"Biasucci LM, Liuzzo G, Grillo RL, Caligiuri G, Rebuzzi AG, Buffon A, Summaria F, Ginnetti F, Fadda G, Maseri A. Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation. 1999;99:855\u201360.","journal-title":"Circulation"},{"key":"937_CR92","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1086\/655472","volume":"202","author":"PJ van de Berg","year":"2010","unstructured":"van de Berg PJ, Heutinck KM, Raabe R, Minnee RC, Young SL, van Donselaar-van der Pant KA, Bemelman FJ, van Lier RA, ten Berge IJ. Human cytomegalovirus induces systemic immune activation characterized by a type 1 cytokine signature. J Infect Dis. 2010;202:690\u20139.","journal-title":"J Infect Dis"},{"key":"937_CR93","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s11239-011-0662-x","volume":"33","author":"M Popovic","year":"2012","unstructured":"Popovic M, Smiljanic K, Dobutovic B, Syrovets T, Simmet T, Isenovic ER. Human cytomegalovirus infection and atherothrombosis. J Thromb Thrombolysis. 2012;33:160\u201372.","journal-title":"J Thromb Thrombolysis"},{"key":"937_CR94","doi-asserted-by":"publisher","first-page":"F47","DOI":"10.1084\/jem.194.9.f47","volume":"194","author":"WA Muller","year":"2001","unstructured":"Muller WA. New mechanisms and pathways for monocyte recruitment. J Exp Med. 2001;194:F47\u201351.","journal-title":"J Exp Med"},{"key":"937_CR95","doi-asserted-by":"publisher","first-page":"6400","DOI":"10.1158\/0008-5472.CAN-17-1612","volume":"72","author":"RL Bakst","year":"2017","unstructured":"Bakst RL, Xiong H, Chen CH, Deborde S, Lyubchik A, Zhou Y, He S, McNamara WF, Lee SY, Olson OC, et al. Inflammatory monocytes promote perineural invasion via CCL2-mediated recruitment and cathepsin B expression. Cancer Res. 2017;72:6400.","journal-title":"Cancer Res"},{"key":"937_CR96","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.bbalip.2009.06.004","volume":"1791","author":"AR Silva","year":"2009","unstructured":"Silva AR, Pacheco P, Vieira-de-Abreu A, Maya-Monteiro CM, D'Alegria B, Magalhaes KG, de Assis EF, Bandeira-Melo C, Castro-Faria-Neto HC, Bozza PT. Lipid bodies in oxidized LDL-induced foam cells are leukotriene-synthesizing organelles: a MCP-1\/CCL2 regulated phenomenon. Biochim Biophys Acta. 2009;1791:1066\u201375.","journal-title":"Biochim Biophys Acta"},{"key":"937_CR97","doi-asserted-by":"publisher","first-page":"42","DOI":"10.14797\/mdcj-8-2-42","volume":"8","author":"M Izadi","year":"2012","unstructured":"Izadi M, Fazel M, Saadat SH, Nasseri MH, Ghasemi M, Dabiri H, Aryan RS, Esfahani AA, Ahmadi A, Kazemi-Saleh D, et al. Cytomegalovirus localization in atherosclerotic plaques is associated with acute coronary syndromes: report of 105 patients. Methodist Debakey Cardiovasc J. 2012;8:42\u20136.","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"937_CR98","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1161\/01.RES.79.6.1143","volume":"79","author":"E Speir","year":"1996","unstructured":"Speir E, Shibutani T, Yu ZX, Ferrans V, Epstein SE. Role of reactive oxygen intermediates in cytomegalovirus gene expression and in the response of human smooth muscle cells to viral infection. Circ Res. 1996;79:1143\u201352.","journal-title":"Circ Res"},{"key":"937_CR99","doi-asserted-by":"publisher","first-page":"19468","DOI":"10.1073\/pnas.0810740105","volume":"105","author":"J Schroer","year":"2008","unstructured":"Schroer J, Shenk T. Inhibition of cyclooxygenase activity blocks cell-to-cell spread of human cytomegalovirus. Proc Natl Acad Sci U S A. 2008;105:19468\u201373.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"937_CR100","doi-asserted-by":"publisher","first-page":"3932","DOI":"10.1073\/pnas.052713799","volume":"99","author":"H Zhu","year":"2002","unstructured":"Zhu H, Cong JP, Yu D, Bresnahan WA, Shenk TE. Inhibition of cyclooxygenase 2 blocks human cytomegalovirus replication. Proc Natl Acad Sci U S A. 2002;99:3932\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"937_CR101","doi-asserted-by":"publisher","first-page":"III27","DOI":"10.1161\/01.CIR.0000115644.35804.8B","volume":"109","author":"J Davignon","year":"2004","unstructured":"Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation. 2004;109:III27\u201332.","journal-title":"Circulation"},{"key":"937_CR102","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1128\/JVI.01910-07","volume":"82","author":"BJ Ryckman","year":"2008","unstructured":"Ryckman BJ, Rainish BL, Chase MC, Borton JA, Nelson JA, Jarvis MA, Johnson DC. Characterization of the human cytomegalovirus gH\/gL\/UL128-131 complex that mediates entry into epithelial and endothelial cells. J Virol. 2008;82:60\u201370.","journal-title":"J Virol"},{"key":"937_CR103","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1078\/0171-2985-00216","volume":"207","author":"AE Gharavi","year":"2003","unstructured":"Gharavi AE, Pierangeli SS, Harris EN. Viral origin of antiphospholipid antibodies: endothelial cell activation and thrombus enhancement by CMV peptide-induced APL antibodies. Immunobiology. 2003;207:37\u201342.","journal-title":"Immunobiology"},{"key":"937_CR104","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1155\/2012\/987476","volume":"23","author":"D Prochnau","year":"2012","unstructured":"Prochnau D, Straube E, Figulla HR, Rodel J. Supra-additive expression of interleukin-6, interleukin-8 and basic fibroblast growth factor in vascular smooth muscle cells following coinfection with Chlamydia pneumoniae and cytomegalovirus as a novel link between infection and atherosclerosis. Can J Infect Dis Med Microbiol. 2012;23:e26\u201330.","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"937_CR105","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1164\/ajrccm.155.6.9196118","volume":"155","author":"PK Koskinen","year":"1997","unstructured":"Koskinen PK, Kallio EA, Bruggeman CA, Lemstrom KB. Cytomegalovirus infection enhances experimental obliterative bronchiolitis in rat tracheal allografts. Am J Respir Crit Care Med. 1997;155:2078\u201388.","journal-title":"Am J Respir Crit Care Med"},{"key":"937_CR106","doi-asserted-by":"publisher","first-page":"e1000967","DOI":"10.1371\/journal.ppat.1000967","volume":"6","author":"F Grey","year":"2010","unstructured":"Grey F, Tirabassi R, Meyers H, Wu G, McWeeney S, Hook L, Nelson JA. A viral microRNA down-regulates multiple cell cycle genes through mRNA 5'UTRs. PLoS Pathog. 2010;6:e1000967.","journal-title":"PLoS Pathog"},{"key":"937_CR107","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.celrep.2016.05.070","volume":"16","author":"H Low","year":"2016","unstructured":"Low H, Mukhamedova N, Cui HL, McSharry BP, Avdic S, Hoang A, Ditiatkovski M, Liu Y, Fu Y, Meikle PJ, et al. Cytomegalovirus restructures lipid rafts via a US28\/CDC42-mediated pathway, enhancing cholesterol efflux from host cells. Cell Rep. 2016;16:186\u2013200.","journal-title":"Cell Rep"},{"key":"937_CR108","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0021-9150(03)00295-8","volume":"170","author":"D Rott","year":"2003","unstructured":"Rott D, Zhu J, Zhou YF, Burnett MS, Zalles-Ganley A, Epstein SE. IL-6 is produced by splenocytes derived from CMV-infected mice in response to CMV antigens, and induces MCP-1 production by endothelial cells: a new mechanistic paradigm for infection-induced atherogenesis. Atherosclerosis. 2003;170:223\u20138.","journal-title":"Atherosclerosis"},{"key":"937_CR109","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.placenta.2010.10.012","volume":"32","author":"S Lager","year":"2011","unstructured":"Lager S, Jansson N, Olsson AL, Wennergren M, Jansson T, Powell TL. Effect of IL-6 and TNF-alpha on fatty acid uptake in cultured human primary trophoblast cells. Placenta. 2011;32:121\u20137.","journal-title":"Placenta"},{"key":"937_CR110","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1159\/000447880","volume":"39","author":"L Li","year":"2016","unstructured":"Li L, Li Y, Dai Z, Liu M, Wang B, Liu S, Wang L, Chen L, Tan Y, Wu G. Lipid metabolism in vascular smooth muscle cells Infuenced by HCMV infection. Cell Physiol Biochem. 2016;39:1804\u201312.","journal-title":"Cell Physiol Biochem"},{"key":"937_CR111","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1177\/0897190009356548","volume":"23","author":"PP Dobesh","year":"2010","unstructured":"Dobesh PP, Swahn SM, Peterson EJ, Olsen KM. Statins in sepsis. J Pharm Pract. 2010;23:38\u201349.","journal-title":"J Pharm Pract"},{"key":"937_CR112","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1194\/jlr.R300019-JLR200","volume":"45","author":"W Khovidhunkit","year":"2004","unstructured":"Khovidhunkit W, Kim MS, Memon RA, Shigenaga JK, Moser AH, Feingold KR, Grunfeld C. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res. 2004;45:1169\u201396.","journal-title":"J Lipid Res"},{"key":"937_CR113","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.virol.2010.04.026","volume":"404","author":"V Sanchez","year":"2010","unstructured":"Sanchez V, Dong JJ. Alteration of lipid metabolism in cells infected with human cytomegalovirus. Virology. 2010;404:71\u20137.","journal-title":"Virology"},{"key":"937_CR114","doi-asserted-by":"crossref","first-page":"e6389","DOI":"10.1590\/1414-431x20176389","volume":"50","author":"N Guo","year":"2017","unstructured":"Guo N, Zhang N, Yan L, Cao X, Lv F, Wang J, Wang Y, Cong H. Down-regulation of single-stranded DNA-binding protein 1 expression induced by HCMV infection promotes lipid accumulation in cells. Braz J Med Biol Res. 2017;50:e6389.","journal-title":"Braz J Med Biol Res"},{"key":"937_CR115","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1172\/JCI119019","volume":"98","author":"YF Zhou","year":"1996","unstructured":"Zhou YF, Guetta E, Yu ZX, Finkel T, Epstein SE. Human cytomegalovirus increases modified low density lipoprotein uptake and scavenger receptor mRNA expression in vascular smooth muscle cells. J Clin Invest. 1996;98:2129\u201338.","journal-title":"J Clin Invest"},{"key":"937_CR116","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2174\/1874357901711010015","volume":"11","author":"S Pasquereau","year":"2017","unstructured":"Pasquereau S, Al Moussawi F, Karam W, Diab Assaf M, Kumar A, Herbein G. Cytomegalovirus, macrophages and breast cancer. Open Virol J. 2017;11:15\u201327.","journal-title":"Open Virol J"},{"key":"937_CR117","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.canlet.2016.10.022","volume":"384","author":"GP Joseph","year":"2017","unstructured":"Joseph GP, McDermott R, Baryshnikova MA, Cobbs CS, Ulasov IV. Cytomegalovirus as an oncomodulatory agent in the progression of glioma. Cancer Lett. 2017;384:79\u201385.","journal-title":"Cancer Lett"},{"key":"937_CR118","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13027-015-0039-4","volume":"10","author":"K Schlick","year":"2015","unstructured":"Schlick K, Grundbichler M, Auberger J, Kern JM, Hell M, Hohla F, Hopfinger G, Greil R. Cytomegalovirus reactivation and its clinical impact in patients with solid tumors. Infect Agent Cancer. 2015;10:45.","journal-title":"Infect Agent Cancer"},{"key":"937_CR119","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.3892\/mmr.2015.3668","volume":"12","author":"Y Li","year":"2015","unstructured":"Li Y, Guo Y, Chen Y, Wang Y, You Y, Yang Q, Weng X, Li Q, Zhu X, Zhou B, et al. Establishment of an interleukin-1beta-induced inflammation-activated endothelial cell-smooth muscle cell-mononuclear cell co-culture model and evaluation of the anti-inflammatory effects of tanshinone IIA on atherosclerosis. Mol Med Rep. 2015;12:1665\u201376.","journal-title":"Mol Med Rep"},{"key":"937_CR120","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s12265-012-9428-x","volume":"6","author":"YJ Tang-Feldman","year":"2013","unstructured":"Tang-Feldman YJ, Lochhead SR, Lochhead GR, Yu C, George M, Villablanca AC, Pomeroy C. Murine cytomegalovirus (MCMV) infection upregulates P38 MAP kinase in aortas of Apo E KO mice: a molecular mechanism for MCMV-induced acceleration of atherosclerosis. J Cardiovasc Transl Res. 2013;6:54\u201364.","journal-title":"J Cardiovasc Transl Res"},{"key":"937_CR121","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1126\/science.8023160","volume":"265","author":"E Speir","year":"1994","unstructured":"Speir E, Modali R, Huang ES, Leon MB, Shawl F, Finkel T, Epstein SE. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science. 1994;265:391\u20134.","journal-title":"Science"},{"key":"937_CR122","doi-asserted-by":"publisher","first-page":"8028","DOI":"10.1128\/JVI.74.17.8028-8037.2000","volume":"74","author":"JP Castillo","year":"2000","unstructured":"Castillo JP, Yurochko AD, Kowalik TF. Role of human cytomegalovirus immediate-early proteins in cell growth control. J Virol. 2000;74:8028\u201337.","journal-title":"J Virol"},{"key":"937_CR123","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1161\/01.CIR.99.13.1656","volume":"99","author":"K Tanaka","year":"1999","unstructured":"Tanaka K, Zou JP, Takeda K, Ferrans VJ, Sandford GR, Johnson TM, Finkel T, Epstein SE. Effects of human cytomegalovirus immediate-early proteins on p53-mediated apoptosis in coronary artery smooth muscle cells. Circulation. 1999;99:1656\u20139.","journal-title":"Circulation"},{"key":"937_CR124","doi-asserted-by":"publisher","first-page":"e45686","DOI":"10.1371\/journal.pone.0045686","volume":"7","author":"E Poole","year":"2012","unstructured":"Poole E, Bain M, Teague L, Takei Y, Laskey R, Sinclair J. The cellular protein MCM3AP is required for inhibition of cellular DNA synthesis by the IE86 protein of human cytomegalovirus. PLoS One. 2012;7:e45686.","journal-title":"PLoS One"},{"key":"937_CR125","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1006\/bbrc.1999.0387","volume":"256","author":"YF Zhou","year":"1999","unstructured":"Zhou YF, Yu ZX, Wanishsawad C, Shou M, Epstein SE. The immediate early gene products of human cytomegalovirus increase vascular smooth muscle cell migration, proliferation, and expression of PDGF beta-receptor. Biochem Biophys Res Commun. 1999;256:608\u201313.","journal-title":"Biochem Biophys Res Commun"},{"key":"937_CR126","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.cardiores.2005.03.012","volume":"67","author":"B Reinhardt","year":"2005","unstructured":"Reinhardt B, Mertens T, Mayr-Beyrle U, Frank H, Luske A, Schierling K, Waltenberger J. HCMV infection of human vascular smooth muscle cells leads to enhanced expression of functionally intact PDGF beta-receptor. Cardiovasc Res. 2005;67:151\u201360.","journal-title":"Cardiovasc Res"},{"key":"937_CR127","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1067\/mhj.2001.113572","volume":"141","author":"H Kervinen","year":"2001","unstructured":"Kervinen H, Palosuo T, Manninen V, Tenkanen L, Vaarala O, Manttari M. Joint effects of C-reactive protein and other risk factors on acute coronary events. Am Heart J. 2001;141:580\u20135.","journal-title":"Am Heart J"},{"key":"937_CR128","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1080\/00015458.2005.11679782","volume":"105","author":"E Corrado","year":"2005","unstructured":"Corrado E, Novo S. Role of inflammation and infection in vascular disease. Acta Chir Belg. 2005;105:567\u201379.","journal-title":"Acta Chir Belg"},{"key":"937_CR129","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1177\/1538574410362922","volume":"44","author":"B Sadowitz","year":"2010","unstructured":"Sadowitz B, Maier KG, Gahtan V. Basic science review: Statin therapy--part I: the pleiotropic effects of statins in cardiovascular disease. Vasc Endovasc Surg. 2010;44:241\u201351.","journal-title":"Vasc Endovasc Surg"},{"key":"937_CR130","doi-asserted-by":"publisher","first-page":"e1004811","DOI":"10.1371\/journal.ppat.1004811","volume":"11","author":"JL Hsu","year":"2015","unstructured":"Hsu JL, van den Boomen DJ, Tomasec P, Weekes MP, Antrobus R, Stanton RJ, Ruckova E, Sugrue D, Wilkie GS, Davison AJ, et al. Plasma membrane profiling defines an expanded class of cell surface proteins selectively targeted for degradation by HCMV US2 in cooperation with UL141. PLoS Pathog. 2015;11:e1004811.","journal-title":"PLoS Pathog"},{"key":"937_CR131","first-page":"179","volume":"36","author":"MK Froberg","year":"2006","unstructured":"Froberg MK, Dannen D, Adams A, Parker-Thornburg J, Kolattukudy P. Murine cytomegalovirus infection markedly reduces serum MCP-1 levels in MCP-1 transgenic mice. Ann Clin Lab Sci. 2006;36:179\u201384.","journal-title":"Ann Clin Lab Sci"},{"key":"937_CR132","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1161\/01.HYP.0000179045.95915.b0","volume":"46","author":"K Chen","year":"2005","unstructured":"Chen K, Chen J, Liu Y, Xie J, Li D, Sawamura T, Hermonat PL, Mehta JL. Adhesion molecule expression in fibroblasts: alteration in fibroblast biology after transfection with LOX-1 plasmids. Hypertension. 2005;46:622\u20137.","journal-title":"Hypertension"},{"key":"937_CR133","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1182\/blood-2007-08-107730","volume":"111","author":"CA Bolovan-Fritts","year":"2008","unstructured":"Bolovan-Fritts CA, Spector SA. Endothelial damage from cytomegalovirus-specific host immune response can be prevented by targeted disruption of fractalkine-CX3CR1 interaction. Blood. 2008;111:175\u201382.","journal-title":"Blood"},{"key":"937_CR134","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1093\/infdis\/171.2.263","volume":"171","author":"WJ Waldman","year":"1995","unstructured":"Waldman WJ, Knight DA, Huang EH, Sedmak DD. Bidirectional transmission of infectious cytomegalovirus between monocytes and vascular endothelial cells: an in vitro model. J Infect Dis. 1995;171:263\u201372.","journal-title":"J Infect Dis"},{"key":"937_CR135","doi-asserted-by":"publisher","first-page":"441","DOI":"10.2217\/fmb.12.12","volume":"7","author":"G Gerna","year":"2012","unstructured":"Gerna G. Endothelial cells and CMV dissemination. Future Microbiol. 2012;7:441\u20134.","journal-title":"Future Microbiol"},{"key":"937_CR136","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1161\/01.RES.81.1.8","volume":"81","author":"E Guetta","year":"1997","unstructured":"Guetta E, Guetta V, Shibutani T, Epstein SE. Monocytes harboring cytomegalovirus: interactions with endothelial cells, smooth muscle cells, and oxidized low-density lipoprotein. Possible mechanisms for activating virus delivered by monocytes to sites of vascular injury. Circ Res. 1997;81:8\u201316.","journal-title":"Circ Res"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-018-0937-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T23:49:28Z","timestamp":1751327368000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-018-0937-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,6]]},"references-count":136,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["937"],"URL":"https:\/\/doi.org\/10.1186\/s12985-018-0937-3","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,6]]},"assertion":[{"value":"6 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing financial interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"31"}}